Peer-Review Report of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (5578)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Jul 26, 2024 (publication date) through May 3, 2026
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Cardiology
ISSN
1949-8462
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| Mohyeldin M, Abuelgasim AS, Mustafa AM. Proprotein convertase subtilisin/kexin type 9 inhibitors in peripheral artery disease: A review of efficacy, safety, and outcomes. World J Cardiol 2024; 16(7): 397-401 [PMID: 39086889 DOI: 10.4330/wjc.v16.i7.397] |
|
|
|
| All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply. | |
| For: | Mohyeldin M, Abuelgasim AS, Mustafa AM. Proprotein convertase subtilisin/kexin type 9 inhibitors in peripheral artery disease: A review of efficacy, safety, and outcomes. World J Cardiol 2024; 16(7): 397-401 [PMID: 39086889 DOI: 10.4330/wjc.v16.i7.397] |
|---|---|
| URL: | https://www.wjgnet.com/1949-8462/full/v16/i7/397.htm |
| Number | Citing Articles |
| 1 |
Stanislav Kotlyarov. Immunology of atherosclerosis: problems and prospects of immunotherapy. Vessel Plus 2025; doi: 10.20517/2574-1209.2025.40
|
| 2 |
Dwi Ariyanti, Muhammad Isra Rafidin Rayyan, Hammam Arif Shabri, Nurwahyudi Nurwahyudi, Muhammad Daffa Husniatama, Rifaldy Nabiel Erisadana, Sabila Larasati, Ali Mustofa, Novia Nurul Faizah, Johanes Nugroho Eko Putranto, Firas Farisi Alkaff, Pandit Bagus Tri Saputra. Beyond maximally tolerated statins: PCSK9 inhibitors as a critical adjunct for cardiovascular risk reduction in peripheral artery disease—a systematic review and meta-analysis. Current Medical Research and Opinion 2026; : 1 doi: 10.1080/03007995.2026.2662127
|